Thorsten Lehr
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 29
- Pharmacogenetics and Drug Metabolism 27
- Antibiotics Pharmacokinetics and Efficacy 6
- Co-authors
- Sebastian Haertter (8 shared papers)Stuart J. Connolly (5 shared papers)Paul Reilly (5 shared papers)Michael D. Ezekowitz (4 shared papers)Lars Wallentin (4 shared papers)Salim Yusuf (4 shared papers)Matthias Schwab (23 shared papers)John W. Eikelboom (3 shared papers)
- Journals
- Pharmaceutics (15 papers)CPT Pharmacometrics & Systems Pharmacology (13 papers)Clinical Pharmacokinetics (11 papers)Clinical Pharmacology & Therapeutics (6 papers)Cancer Chemotherapy and Pharmacology (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Thorsten Lehr
118 papers receiving 3.8k citations
Thorsten Lehr's Hit Papers
Peers
Comparison fields: 5 of 143
- Internal Medicine 557
- Pharmacology 583
- Cardiology and Cardiovascular Medicine 1.3k
- Hepatology 318
- Toxicology 72
Countries citing papers authored by Thorsten Lehr
This map shows the geographic impact of Thorsten Lehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Lehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Lehr more than expected).
Fields of papers citing papers by Thorsten Lehr
This network shows the impact of papers produced by Thorsten Lehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Lehr. The network helps show where Thorsten Lehr may publish in the future.
Co-authors
The 25 scholars most cited alongside Thorsten Lehr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients Hit paper breakdown → | 2013 | 636 |
| 2 | 2016 | 284 | |
| 3 | 2011 | 243 | |
| 4 | 2013 | 206 | |
| 5 | 2016 | 172 | |
| 6 | 2013 | 160 | |
| 7 | 2012 | 135 | |
| 8 | 2018 | 134 | |
| 9 | 2020 | 84 | |
| 10 | 2019 | 81 | |
| 11 | 2011 | 78 | |
| 12 | 2015 | 66 | |
| 13 | 2015 | 61 | |
| 14 | 2017 | 56 | |
| 15 | 2019 | 49 | |
| 16 | 2018 | 49 | |
| 17 | 2021 | 48 | |
| 18 | 2019 | 41 | |
| 19 | 2013 | 40 | |
| 20 | 2020 | 35 |
About Thorsten Lehr
Thorsten Lehr is a scholar working on Pharmacology, Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology and Pediatrics, Perinatology and Child Health, having authored 120 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (27 papers), Atrial Fibrillation Management and Outcomes (13 papers), Drug Transport and Resistance Mechanisms (9 papers), Computational Drug Discovery Methods (8 papers), Analytical Methods in Pharmaceuticals (8 papers), Analytical Chemistry and Chromatography (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). The work is most often cited by research in Internal Medicine (557 citations), Pharmacology (583 citations), Cardiology and Cardiovascular Medicine (1.3k citations), Hepatology (318 citations) and Toxicology (72 citations). Thorsten Lehr has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Sebastian Haertter, Stuart J. Connolly, Paul Reilly, Michael D. Ezekowitz, Lars Wallentin, Salim Yusuf, Matthias Schwab, John W. Eikelboom, Dominik Selzer and Nina Hanke. Their work appears in journals such as Pharmaceutics, CPT Pharmacometrics & Systems Pharmacology, Clinical Pharmacokinetics, Clinical Pharmacology & Therapeutics and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.